Helen Meadows

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

R.D. James, Rob Glynne‐Jones, Helen Meadows et al. · The Lancet Oncology · 2013 · 733 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin

S.J. Arnott, David Cunningham, James Gallagher et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1996 · 727 citations

Medicine, Oncology, Radiation Oncology +8

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

John Northover, Rob Glynne‐Jones, David Sebag‐Montefiore et al. · British Journal of Cancer · 2010 · 428 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

Rob Glynne‐Jones, Nicholas Counsell, Philip Quirke et al. · Annals of Oncology · 2014 · 297 citations · Full text

Medicine, Oncology, Surgery +16

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Rob Glynne‐Jones, David Sebag‐Montefiore, Helen Meadows et al. · The Lancet Oncology · 2017 · 183 citations · Full text

Medicine, Radiation Oncology, Clinical Radiation Oncology +1